MyBCTeam

What are the recommended treatment options for recurrent triple-negative breast cancer after initial treatment with chemotherapy, radiation, and surgery?

When triple-negative breast cancer returns after initial treatment, several options may be available depending on your specific situation:

Immunotherapy Options
- Show Full Answer

What are the recommended treatment options for recurrent triple-negative breast cancer after initial treatment with chemotherapy, radiation, and surgery?

When triple-negative breast cancer returns after initial treatment, several options may be available depending on your specific situation:

Immunotherapy Options:
- Pembrolizumab (Keytruda) if your cancer cells make the PD-L1 protein
- Pembrolizumab may also help if you have changes in mismatch repair genes

Targeted Therapies:
- PARP inhibitors like olaparib (Lynparza) or talazoparib (Talzenna) if you have BRCA1 or BRCA2 gene mutations
- Sacituzumab govitecan-hziy (Trodelvy) for metastatic or inoperable breast cancer, especially if tests show you don't have common gene or protein changes

Additional Treatments:
In some cases, surgery, immunotherapy, and chemotherapy can be used again for recurrent disease.

Clinical trials are also an important option to consider, as new medications are constantly being investigated. You can discuss eligible trials with your doctor or search at ClinicalTrials.gov.

The specific treatment plan will depend on factors like where the cancer has returned, whether it has spread, and the genetic characteristics of your cancer cells. Your oncologist can help determine which approach might work best for your individual situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Triple-Negative Breast Cancer Recurrence Rate: 8 Things to Know

How Fast Does Triple-Negative Cancer Grow? 4 Reasons It’s Aggressive